Component

Lithium chloride

Context-specific entity; species, compartment and exposure are stated on each claim.

6 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. LiCl reduced intracellular and secreted GAG sulfation in wild-type mouse fibroblasts, with no further reduction after Bpnt2 knockout.

    Lithium ion (Li+) → Mouse fibroblast glycosaminoglycan sulfation source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary full text
    experimental_model
    Mouse embryonic fibroblasts; 10 mM LiCl versus matched NaCl.
    limitations
    High experimental exposure; knockout occlusion supports a pathway but does not prove clinical cartilage damage.
    nutrient_topic
    Lithium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Lithium
    plain_language
    The lithium response depended on this Golgi enzyme.
    primary_references
    Sulfation of glycosaminoglycans depends on the catalytic activity of lithium-inhibited phosphatase BPNT2 in vitro. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34634304/ · DOI 10.1016/j.jbc.2021.101293

    Lithium: metal-sensitive enzymes, transport and cross-nutrient mechanisms (2026-09-19) · lines 160–166

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse embryonic fibroblasts; 10 mM LiCl versus matched NaCl. · source_derived_draft · unverified_draft

    ## lithium-bpnt2-lithium-gag The lithium response depended on this Golgi enzyme. LiCl reduced intracellular and secreted GAG sulfation in wild-type mouse fibroblasts, with no further reduction after Bpnt2 knockout. Model: Mouse embryonic fibroblasts; 10 mM LiCl versus matched NaCl. Limitations: High experimental exposure; knockout occlusion supports a pathway but does not prove clinical cartilage damage. Evidence access: Primary full text Sulfation of glycosaminoglycans depends on the catalytic activity of lithium-inhibited phosphatase BPNT2 in vitro. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34634304/ · DOI 10.1016/j.jbc.2021.101293
    Complete structured claim and evidence

  2. LiCl stimulated glycogen synthesis from glucose in normal and diabetic-rat hepatocytes, with increased glycogen-synthase activity ratio.

    Lithium ion (Li+) → Rat hepatocyte glycogen synthesis source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Rat hepatocytes; 20 mM glucose; concentration/time dependence.
    limitations
    Isolated cells, not a diabetes treatment trial.
    nutrient_topic
    Lithium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Lithium
    plain_language
    A carbohydrate-storage response depends on the available carbon source.
    primary_references
    Lithium restores glycogen synthesis from glucose in hepatocytes from diabetic rats. · 1993 · https://pubmed.ncbi.nlm.nih.gov/8460950/ · DOI 10.1006/abbi.1993.1164

    Lithium: metal-sensitive enzymes, transport and cross-nutrient mechanisms (2026-09-19) · lines 304–310

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat hepatocytes; 20 mM glucose; concentration/time dependence. · source_derived_draft · unverified_draft

    ## lithium-glycogen-glucose A carbohydrate-storage response depends on the available carbon source. LiCl stimulated glycogen synthesis from glucose in normal and diabetic-rat hepatocytes, with increased glycogen-synthase activity ratio. Model: Rat hepatocytes; 20 mM glucose; concentration/time dependence. Limitations: Isolated cells, not a diabetes treatment trial. Evidence access: Primary abstract Lithium restores glycogen synthesis from glucose in hepatocytes from diabetic rats. · 1993 · https://pubmed.ncbi.nlm.nih.gov/8460950/ · DOI 10.1006/abbi.1993.1164
    Complete structured claim and evidence

  3. Lithium treatment increased mono/bis-phosphorylated inositol species in COS-7 cells, consistent with inhibited recycling.

    Lithium ion (Li+) → Inositol monophosphates source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary full text
    experimental_model
    Monkey COS-7 cells; 10 mM LiCl, 24-hour metabolite assay.
    limitations
    Combined IP1–2 measurement; this exposure exceeds typical clinical serum concentrations.
    nutrient_topic
    Lithium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Lithium
    plain_language
    Blocking recycling lets upstream material accumulate.
    primary_references
    Lithium induces autophagy by inhibiting inositol monophosphatase. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16186256/ · DOI 10.1083/jcb.200504035

    Lithium: metal-sensitive enzymes, transport and cross-nutrient mechanisms (2026-09-19) · lines 72–78

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Monkey COS-7 cells; 10 mM LiCl, 24-hour metabolite assay. · source_derived_draft · unverified_draft

    ## lithium-inositol-phosphate-accumulation Blocking recycling lets upstream material accumulate. Lithium treatment increased mono/bis-phosphorylated inositol species in COS-7 cells, consistent with inhibited recycling. Model: Monkey COS-7 cells; 10 mM LiCl, 24-hour metabolite assay. Limitations: Combined IP1–2 measurement; this exposure exceeds typical clinical serum concentrations. Evidence access: Primary full text Lithium induces autophagy by inhibiting inositol monophosphatase. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16186256/ · DOI 10.1083/jcb.200504035
    Complete structured claim and evidence

  4. Lithium accelerated clearance of expressed mutant huntingtin and alpha-synuclein in inducible PC12 models.

    Lithium ion (Li+) → Rat PC12-cell clearance of expressed mutant proteins source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary full text
    experimental_model
    Rat PC12; 10 mM LiCl; expression switched off before clearance measurement.
    limitations
    Engineered protein models do not establish treatment of Huntington or Parkinson disease.
    nutrient_topic
    Lithium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Lithium
    plain_language
    Recycling changed the persistence of aggregation-prone proteins.
    primary_references
    Lithium induces autophagy by inhibiting inositol monophosphatase. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16186256/ · DOI 10.1083/jcb.200504035

    Lithium: metal-sensitive enzymes, transport and cross-nutrient mechanisms (2026-09-19) · lines 96–102

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat PC12; 10 mM LiCl; expression switched off before clearance measurement. · source_derived_draft · unverified_draft

    ## lithium-protein-clearance Recycling changed the persistence of aggregation-prone proteins. Lithium accelerated clearance of expressed mutant huntingtin and alpha-synuclein in inducible PC12 models. Model: Rat PC12; 10 mM LiCl; expression switched off before clearance measurement. Limitations: Engineered protein models do not establish treatment of Huntington or Parkinson disease. Evidence access: Primary full text Lithium induces autophagy by inhibiting inositol monophosphatase. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16186256/ · DOI 10.1083/jcb.200504035
    Complete structured claim and evidence

  5. LiCl inhibited GSK3beta and stabilized free beta-catenin in cultured human thyrocytes.

    Lithium ion (Li+) → Human beta-catenin / CTNNB1 source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Primary and neoplastic human-cell preparations; dose-response assays.
    limitations
    Historical cell-line identities and experimental conditions limit extrapolation.
    nutrient_topic
    Lithium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Lithium
    plain_language
    Thyroid growth signaling can change independently of hormone release.
    primary_references
    Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16322400/ · DOI 10.1530/eje.1.02038

    Lithium: metal-sensitive enzymes, transport and cross-nutrient mechanisms (2026-09-19) · lines 408–414

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary and neoplastic human-cell preparations; dose-response assays. · source_derived_draft · unverified_draft

    ## lithium-thyroid-beta-catenin Thyroid growth signaling can change independently of hormone release. LiCl inhibited GSK3beta and stabilized free beta-catenin in cultured human thyrocytes. Model: Primary and neoplastic human-cell preparations; dose-response assays. Limitations: Historical cell-line identities and experimental conditions limit extrapolation. Evidence access: Primary abstract Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16322400/ · DOI 10.1530/eje.1.02038
    Complete structured claim and evidence

  6. At 5 mM LiCl, thyrocyte proliferation increased; dominant-negative TCF4 reduced this response by about half.

    Lithium ion (Li+) → Human cultured-thyrocyte proliferation source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human cultured thyrocytes; TCF4 versus CREB pathway perturbation.
    limitations
    High cell-culture exposure; not a quantified human goiter or cancer risk.
    nutrient_topic
    Lithium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Lithium
    plain_language
    Blocking a downstream regulator weakened the growth response.
    primary_references
    Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16322400/ · DOI 10.1530/eje.1.02038

    Lithium: metal-sensitive enzymes, transport and cross-nutrient mechanisms (2026-09-19) · lines 416–422

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cultured thyrocytes; TCF4 versus CREB pathway perturbation. · source_derived_draft · unverified_draft

    ## lithium-thyroid-wnt-growth Blocking a downstream regulator weakened the growth response. At 5 mM LiCl, thyrocyte proliferation increased; dominant-negative TCF4 reduced this response by about half. Model: Human cultured thyrocytes; TCF4 versus CREB pathway perturbation. Limitations: High cell-culture exposure; not a quantified human goiter or cancer risk. Evidence access: Primary abstract Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16322400/ · DOI 10.1530/eje.1.02038
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards